Literature DB >> 28827041

Epilepsy and sleep disorders improve in adolescents and adults with Angelman syndrome: A multicenter study on 46 patients.

Chiara Sueri1, Edoardo Ferlazzo2, Maurizio Elia3, Paolo Bonanni4, Giovanna Randazzo4, Sara Gasparini5, Tiziana D'Agostino1, Antonino R Sapone1, Michele Ascoli6, Marina A Bellavia6, Vittoria Cianci1, Antonio Gambardella6, Angelo Labate6, Umberto Aguglia5.   

Abstract

OBJECTIVE: Actual knowledge on evolution of Angelman syndrome (AS) relies on questionnaire-based cohort studies, phone interviews, or small retrospective cohort studies focused on specific clinical-genetic features. These reports provide conflicting results. The aim of this study was to assess the long-term outcome of epilepsy, sleep disorders, and EEG in a vast series of AS subjects.
METHODS: We collected patients with genetically confirmed AS, aged ≥14years, followed in three tertiary epilepsy Centers or attending the meetings of the Italian Organization for AS (OrSA). Retrospective clinical and EEG data were retrieved from hospital archives or family documents. At index evaluation (IE) (last visit at tertiary Centers or single visit during OrSA meetings), caregivers were interviewed about anamnestic data and filled questionnaires on sleep disorders and daily-living skills. Patients underwent general and neurologic evaluation, and video-EEG recordings. All available EEGs were analyzed to compare evolution of spike-wave index (SWI) over the years.
RESULTS: Forty-six subjects aged 14-45years were included: 24 from tertiary Centers, 22 from OrSA meetings. During childhood, 42/46 (91.3%) had seizures, which improved over the years in all subjects. Among patients with epilepsy, 27(64%) became seizure-free at a median age of 10years and 4 remained seizure-free even after antiepileptic withdrawal. During childhood, 39/46 (84.8%) had sleep disorders, which improved in 27/39 (69%) over the years. At IE, daily-living skills corresponded to age≤1.6years in 29/46 (63%). Electroencephalogram showed typical AS patterns in 35/46 (76.1%). In EEGs recorded from 10 patients, SWI was not significantly different between infancy/childhood and adolescence/adulthood.
CONCLUSION: Improvement of epilepsy or sleep disorders should not disregard the clinical suspicion of AS in adolescent or adult patients with suggestive features. Drug withdrawal might be considered in the management of epilepsy despite the persistence of epileptiform abnormalities.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiepileptic drugs; EEG; Genetics; Seizures; UBE3A

Mesh:

Year:  2017        PMID: 28827041     DOI: 10.1016/j.yebeh.2017.07.041

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  8 in total

1.  Dystonia in Angelman syndrome: a common, unrecognized clinical finding.

Authors:  Edoardo Ferlazzo; Michele Ascoli; Francesca Abate; Sara Gasparini; Giovanni Mastroianni; Vittoria Cianci; Giulia Ferrigno; Chiara Sueri; Tiziana D'Agostino; Umberto Aguglia
Journal:  J Neurol       Date:  2021-01-23       Impact factor: 4.849

2.  Mirtazapine for sleep disturbances in Angelman syndrome: a retrospective chart review of 8 pediatric cases.

Authors:  Emily Hanzlik; Sarah A Klinger; Robert Carson; Jessica Duis
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

Review 3.  Epilepsy in Angelman syndrome: A scoping review.

Authors:  Debopam Samanta
Journal:  Brain Dev       Date:  2020-09-04       Impact factor: 1.961

4.  Clinical Characterization of Epilepsy in Children With Angelman Syndrome.

Authors:  Daiana Cassater; Mariana Bustamante; Lisa Sach-Peltason; Alexander Rotenberg; Mark Nespeca; Wen-Hann Tan; Lynne M Bird; Joerg F Hipp
Journal:  Pediatr Neurol       Date:  2021-08-31       Impact factor: 3.372

5.  A 19-month-old boy with decreased sleep and a distinctive electroencephalogram pattern.

Authors:  Julie Baughn; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2021-07-01       Impact factor: 4.324

6.  Preserved expressive language as a phenotypic determinant of Mosaic Angelman Syndrome.

Authors:  Robert P Carson; Lynne Bird; Anna K Childers; Ferrin Wheeler; Jessica Duis
Journal:  Mol Genet Genomic Med       Date:  2019-08-10       Impact factor: 2.183

7.  Multi-Method Assessment of Sleep in Children With Angelman Syndrome: A Case-Controlled Study.

Authors:  Jayne Trickett; Chris Oliver; Mary Heald; Hayley Denyer; Andrew Surtees; Emma Clarkson; Paul Gringras; Caroline Richards
Journal:  Front Psychiatry       Date:  2019-11-29       Impact factor: 4.157

Review 8.  Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader-Willi syndrome.

Authors:  Tzong-Shi Wang; Wen-Hsin Tsai; Li-Ping Tsai; Shi-Bing Wong
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.